Methylphenidate Lp Viatris

Methylphenidate Hydrochloride, the active ingredient in Methylphenidate Lp Viatris, is a central nervous system stimulant presented as an oral formulation for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents and adults.

GNH USA supplies Methylphenidate Lp Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylphenidate Hydrochloride is a central nervous system stimulant used for conditions that affect attention and wakefulness.

- Attention deficit hyperactivity disorder (ADHD): Improves concentration, reduces hyperactivity and impulsivity in patients. - Narcolepsy: Decreases excessive daytime sleepiness and helps maintain wakefulness. - Cognitive performance in certain adult populations: May enhance sustained attention when prescribed for off‑label therapeutic reasons under specialist supervision.

Methylphenidate Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Insomnia: Difficulty falling or staying asleep. - Decreased appetite: Reduced hunger leading to weight loss. - Headache: Mild to moderate cranial pain. - Stomach pain: Abdominal discomfort or cramps. - Irritability: Mood changes and increased agitation. - Weight loss: Unintended reduction in body weight.

Serious or Rare Side Effects: - Cardiovascular events: Chest pain, hypertension, or arrhythmias. - Psychosis: Hallucinations or delusional thinking. - Severe allergic reactions: Rash, swelling, or anaphylaxis. - Tics: New or worsening motor or vocal tics. - Priapism: Persistent, painful erection. - Hallucinations: Visual or auditory disturbances.

Before initiating therapy with Methylphenidate Hydrochloride, several safety considerations should be reviewed. - Cardiovascular assessment: Evaluate heart history and blood pressure. - Psychiatric monitoring: Watch for new or worsening mental health symptoms. - Growth monitoring: Track height and weight in pediatric patients. - Potential for abuse: Use only as prescribed and monitor for misuse. - Drug interactions: Review all concomitant medications. - Store at ambient temperature: Keep below 25°C in the original packaging, protect from moisture.

Methylphenidate Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): Risk of hypertensive crisis. - Tricyclic antidepressants: May increase cardiovascular side effects. - Antihypertensive agents: May reduce blood pressure control.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): May increase risk of serotonin syndrome. - Antacids: May affect drug absorption. - Anticonvulsants: May alter plasma concentrations of methylphenidate.